论文部分内容阅读
Erlotinib and gefitinib are among the most widely researched,used and available molecularly targeted therapies for treatment of advanced non-small cell lung cancer(NSCLC).They are both tyrosine kinase inhibitors(TKIs)of the epidermal growth factor recepto